Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression

ABSTRACT: Purpose: To understand the molecular mechanisms underlying the CTX synergization with antibody therapies in resistant niche-specific organs and BM-resident tumors

ORGANISM(S): Mus musculus Homo sapiens

PROVIDER: GSE135997 | GEO | 2019/08/20

REPOSITORIES: GEO